We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Specific Antibody Indicates Route of Parasitic Infection

By LabMedica International staff writers
Posted on 02 Jun 2011
A protein that elicits an antibody to the parasite Toxoplasma gondii may help scientists determine the mode of transmission. More...


The T. gondii embryogenesis-related protein (TgERP) can be detected in the sera of humans and animals by difference gel electrophoresis, in combination with tandem mass spectroscopy and Western blot analysis.

A team of scientists, led by those at the Animal and Natural Resources Institute (Beltsville, MD, USA), selected a recombinant protein from a complementary DNA (cDNA) library constructed from T. gondii sporozoites and it was used for Western blots and probed with sera from T. gondii-infected humans. The investigators used blood sera from laboratory tests performed with pigs and mice, as well as human blood sera from six events of known occurrences of toxoplasmosis.

Serum antibody to the antigen TgERP was detected in humans within 6-8 months of initial oocyst-acquired infection. Of 163 individuals in the acute stage of infection, where anti–T. gondii immunoglobulin M (IgM) was detected in sera, or where the IgG avidity test was less than 30%, 103 (63.2%) had detectable antibodies that reacted with TgERP. Of 176 individuals with unknown infection route and in the chronic stage of infection, where no anti–T. gondii IgM was detected in sera, or with greater than 30% result in the IgG avidity test, antibody to TgERP was detected in 31(17.6%) samples.

The routes of infection include ingestion of food or water contaminated with oocysts from infected cat feces and ingestion of tissue cysts in undercooked or raw meat. Food animals, such as pigs, can also become infected, resulting in people consuming meat products containing tissue cysts. Congenital infection can bring about a range of outcomes for the child, including chronic infection, blindness, mental retardation, and stillbirth. Until now, no tests were able to differentiate between oocyst ingestion and tissue cyst ingestion as the infection source.

In these tests, antibody to TgERP was effectively identified in all pigs exposed to oocyte infection and 90% of people known or suspected to have been exposed to oocysts. The authors conclude that, "TgERP may be useful in detecting exposure to sporozoites in early Toxoplasma infection and implicates oocysts as the agent of infection." The study was published in April 2011, in the Journal of Parasitology.

Related Links:

Animal and Natural Resources Institute




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.